People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Naveris, Inc. | — | Biotechnology | Series B | $33.6M | $126.9M | 2020 |
| Teal Bio, Inc. | — | Biotech / Pharma | Seed | $3.8M | $1.5M | 2021 |
Sophie Kornowski at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sophie Kornowski on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Michael Singer | 1 | 11 |
| Carlo Giovanni Traverso | 1 | 6 |
| James McNally | 1 | 2 |
| Jason Troutner | 1 | 2 |
| Barry Berger | 1 | 1 |
| Philip Grahame Haydon | 1 | 1 |
| Carlo Traverso | 1 | 1 |
| Tony Casciano | 1 | 1 |
| Sophie Giovanni Kornowski | 1 | 1 |
| Anne Stone | 1 | 1 |
| Francis Crispino | 1 | 1 |
| Piyush Gupta | 1 | 1 |
| Philip Stephens | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.